Status:
COMPLETED
Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms
Lead Sponsor:
Milsing d.o.o.
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms.
Detailed Description
Patients allergic to the specific pollen are divided into two groups randomly. One group is being administered Lectranal and the other group is being administered placebo during the period of 6 weeks ...
Eligibility Criteria
Inclusion
- history of seasonal allergic rhinitis symptoms to pollen
- positive skin prick test to pollen
- negative history of seasonal allergic asthma
- male or female older than 18
- female participants must use appropriate contraception
- able to comply to study procedures
Exclusion
- pregnancy
- alcohol or drug abuse
- subject receiving antihistamines , immunotherapy or on hyposensibilisation
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00460538
Start Date
April 1 2007
End Date
November 1 2007
Last Update
April 5 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dubrava University Hospital
Zagreb, Croatia, 10000